interleukin-2 vaccine (ICR)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinterleukin-2 vaccine (ICR)
Drug Alias Namemelanoma vaccine (ICR)IL-2 vaccine (Institute of Cancer Research)
ClassificationBiologics > Protein drugs > Recombinant polypeptideCell and gene therapy > Cell therapy
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitute Of Cancer Research
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A